New Edge Advisors, LLC Charles River Laboratories International, Inc. Transaction History
New Edge Advisors, LLC
- $16.2 Billion
- Q1 2025
A detailed history of New Edge Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 438 shares of CRL stock, worth $78,161. This represents 0.0% of its overall portfolio holdings.
Number of Shares
438
Previous 524
16.41%
Holding current value
$78,161
Previous $96,000
32.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CRL
# of Institutions
624Shares Held
55MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$1.09 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$908 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$765 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$427 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$409 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.08B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...